Clinical Trial Update: A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial evaluating the safety and biological activity of the antibody BNT351 in adults with and without HIV-1 infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BNT351

Snippet

Sponsor: BioNTech SE | Conditions: HIV -1 Infection | Phase 1 | Status: RECRUITING